AT&T CEO Stephenson says deal needed in content-dependent world
April 19, 2018New York’s ‘Fearless Girl’ to stare down the Stock Exchange
April 19, 2018Shire rejects $63 billion Takeda bid as Allergan drops pursuit
at
NEW YORK/LONDON (Reuters) – Rare disease drug maker Shire Plc said on Thursday it had rejected a $63 billion cash-and-stock acquisition offer by Japan’s Takeda Pharmaceutical Co Ltd , while Allergan Plc reversed course on pursuing a rival bid.
Powered by WPeMatico
